N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-7-(3-hydroxypropoxy)-2-[[2-(trifluoromethyl)-1,3-thiazole-5-carbonyl]amino]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-2-(trifluoromethyl)-1,3-thiazole-5-carboxamide
C34H28F6N10O7S2 — CID 155787027
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-7-(3-hydroxypropoxy)-2-[[2-(trifluoromethyl)-1,3-thiazole-5-carbonyl]amino]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-2-(trifluoromethyl)-1,3-thiazole-5-carboxamide
N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-7-(3-hydroxypropoxy)-2-[[2-(trifluoromethyl)-1,3-thiazole-5-carbonyl]amino]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-2-(trifluoromethyl)-1,3-thiazole-5-carboxamide (PubChem CID 155787027) has the molecular formula C34H28F6N10O7S2 and a molecular weight of 866.78 g/mol. Its IUPAC name is N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-7-(3-hydroxypropoxy)-2-[[2-(trifluoromethyl)-1,3-thiazole-5-carbonyl]amino]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-2-(trifluoromethyl)-1,3-thiazole-5-carboxamide.
Molecular Properties
| Compound Name | N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-7-(3-hydroxypropoxy)-2-[[2-(trifluoromethyl)-1,3-thiazole-5-carbonyl]amino]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-2-(trifluoromethyl)-1,3-thiazole-5-carboxamide |
|---|---|
| PubChem CID | 155787027 |
| Molecular Formula | C34H28F6N10O7S2 |
| Molecular Weight | 866.78 g/mol |
| Exact Mass | 866.15 |
| IUPAC Name | N-[5-carbamoyl-1-[(E)-4-[5-carbamoyl-7-(3-hydroxypropoxy)-2-[[2-(trifluoromethyl)-1,3-thiazole-5-carbonyl]amino]benzimidazol-1-yl]but-2-enyl]-7-methoxybenzimidazol-2-yl]-2-(trifluoromethyl)-1,3-thiazole-5-carboxamide |
| SMILES | COc1cc(C(N)=O)cc2nc(NC(=O)c3cnc(C(F)(F)F)s3)n(C/C=C/Cn3c(NC(=O)c4cnc(C(F)(F)F)s4)nc4cc(C(N)=O)cc(OCCCO)c43)c12 |
| InChI | InChI=1S/C34H28F6N10O7S2/c1-56-19-11-15(25(41)52)9-17-23(19)49(31(45-17)47-27(54)21-13-43-29(58-21)33(35,36)37)5-2-3-6-50-24-18(10-16(26(42)53)12-20(24)57-8-4-7-51)46-32(50)48-28(55)22-14-44-30(59-22)34(38,39)40/h2-3,9-14,51H,4-8H2,1H3,(H2,41,52)(H2,42,53)(H,45,47,54)(H,46,48,55)/b3-2+ |
| InChIKey | XEIBXWROYIEDHG-NSCUHMNNSA-N |
| XLogP | 5.07 |
| TPSA | 244.49 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 866.78 |
| LogP ≤ 5 | 5.07 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155787027 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.